Adicet Bio ACET

$ 1.27 2.0%

Quarterly report 2024-Q2
added 08-13-2024

Adicet Bio Income Statement 2011-2024 | ACET

Annual Income Statement Adicet Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	87.4 M	317 M	541 M	64.1 M	289 M	-	-	-	-	-	-	-	-
Shares	43 M	41.1 M	31 M	5.21 M	32.3 M	-	-	-	-	-	-	-	-
Historical Prices	2.03	7.72	17.5	14.1	10.4	60.3	-	-	-	-	-	-	-
Net Income	-143 M	-69.8 M	-62 M	-36.7 M	-28.1 M	11.4 M	34.8 M	33.5 M	29 M	22.3 M	22.3 M	17 M	8.97 M
Revenue	-	-	9.73 M	17.9 M	995 K	638 M	559 M	547 M	510 M	500 M	500 M	444 M	412 M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	17.9	-	141 M	143 M	135 M	115 M	98.3 M	98.3 M	82 M	65.8 M
Operating Income	-152 M	-72.6 M	-61.4 M	-39.2 M	-31.4 M	-15 M	-18.9 M	-	-	-	-	-	-
Interest Expense	25 K	80 K	176 K	134 K	2.33 M	4.53 M	-14.9 M	-	-	-	-	-	-
EBITDA	-146 M	-70 M	-59.9 M	-38 M	-30.2 M	65.2 M	74.2 M	68.2 M	52.4 M	41.4 M	41.4 M	32.3 M	22.1 M
Operating Expenses	152 M	97.5 M	71.2 M	57.1 M	-	110 M	84.8 M	79.1 M	70.4 M	63.9 M	63.9 M	56.7 M	49.3 M
General and Administrative Expenses	26.5 M	26.3 M	22.2 M	22.8 M	8.69 M	102 M	76.8 M	73.2 M	65.2 M	61 M	63.9 M	56.7 M	49.3 M

All numbers in USD currency

Quarterly Income Statement Adicet Bio

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	90.6 M	79.1 M	43.3 M	43 M	43 M	43 M	43 M	41.6 M	40.1 M	39.8 M	39.7 M	31.9 M	31.8 M	26.1 M	39.7 M	5.21 M	2.18 M	2.16 M	2.16 M	2.15 M	35.7 M	29 M	28.1 M	28 M	28 M	21.5 M	5.66 M	4.41 M	4.3 M	2.79 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-29.9 M	-28 M	-	-49.9 M	-32.4 M	-30.9 M	-	-22 M	-22.5 M	4.62 M	-	-14 M	-10.9 M	-21.3 M	-	-14.8 M	-8.46 M	-4.49 M	-28.9 M	-14.8 M	-2.65 M	-4.13 M	-5.76 M	-8.41 M	-13.6 M	-9.86 M	-23.1 M	-3.31 M	-4.06 M	-3.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	25 M	-	3.43 M	4.81 M	-3.98 M	-	3.03 M	7.46 M	2 M	-	-7.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-32.8 M	-30.9 M	-	-52.3 M	-34.9 M	-33.3 M	-	-23 M	-22.7 M	4.71 M	-	-13.7 M	-10.8 M	-21.4 M	-	-13.7 M	-8.63 M	-7.56 M	-29.4 M	-15.2 M	-19.2 M	-11.7 M	-6.36 M	-9.03 M	-14.1 M	-10.2 M	-7.52 M	-3.94 M	-4.06 M	-3.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	2 K	-	1 K	4 K	19 K	-	18 K	18 K	18 K	-	50 K	51 K	50 K	-	50 K	34 K	70 K	-	171 K	847 K	631 K	-	625 K	522 K	341 K	-	635 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-29.2 M	-	-50.7 M	-33.4 M	-32.1 M	-	-22.2 M	-22.3 M	5.06 M	-	-13.3 M	-10.3 M	-21 M	-	-13.4 M	-8.33 M	-7.24 M	-29.4 M	-14.9 M	-19.1 M	-11.7 M	-6.36 M	-9.01 M	-14.1 M	-10.2 M	-7.52 M	-3.94 M	-4.06 M	-3.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	32.8 M	30.9 M	-	52.3 M	34.9 M	33.3 M	-	23 M	22.7 M	20.3 M	-	17.1 M	15.6 M	17.4 M	-	16.7 M	16.1 M	9.56 M	-	8.18 M	19.2 M	11.7 M	-	9.03 M	14.1 M	10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.95 M	6.97 M	-	6.63 M	6.53 M	6.57 M	-	6.42 M	6.53 M	6.8 M	-	5.21 M	5.02 M	5.63 M	-	7.74 M	7.42 M	2.52 M	-	1.85 M	2.62 M	2.84 M	-	2.27 M	2.27 M	2.09 M	-	612 K	637 K	63 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency